Loading...
UK Trademark — IPO
HEALTHCARE DECISION ENGINE
Application UK00914779474 · Expired
Quick Facts
| Application Number | UK00914779474 |
| Status | Expired |
| Owner | Molecular Health GmbH |
| Filed | 2015-11-09 |
| Registered | 2016-05-30 |
| Renewal Due | 2025-11-09 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
HEALTHCARE DECISION ENGINE has a current status of Expired.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 9 — Electrical & IT
Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology; downloadable computer databases containing medical and/or health information or records about or relating to humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans, including biomedical databases containing information about clinical, genomic, molecular, scientific and/or patient specific data, in particular information that clinicians and researchers enable to interpret complex molecular and genomic patient information; computer databases and computer software and algorithms for storing and sorting biomedical information, in particular links to external reference databases, in particular for the alignment and/or integration of biomedical information, updating and expanding global reference data sources across diverse medical disciplines and/or for allowing the immediate access to biomedical information; computer databases containing biomedical information in form of human genome sequences, information about indication and/or classifications of diseases, biomarkers, information about the molecular mechanism of action of drugs, their targets, metabolizing enzymes, information about scientific publications from diverse areas of biomedicine drug-to-drug interactions and/or the status of drug development; downloadable computer software and algorithms for authorizing or providing access to any of these biomedical databases, in particular application software, interface software, software drives, data communication software, interactive computer software; computer software and software components for serving domain-specific user demands; downloadable mobile applications for mobile devices, such as eg smart phones and/or tablet computers, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans.
Class 35 — Advertising & Business
Consulting and research services to employers in the field of offering medical and health care diagnostic and/or treatment support programs to employees and family members and/or domestic partners of employees as an employee benefit.
Class 36 — Financial Services
Administration and provision of programs and services for payment and/or reimbursement of medical and health care diagnostic and/or treatment support programs to employees and family members and/or domestic partners of employees as an employee benefit.
Class 38 — Telecommunications
Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing access to databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes.
Class 42 — Scientific & IT Services
Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and/or pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data, and/or molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; designing and/or developing and/or providing use of searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; designing and/or developing and/or providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; designing and/or developing and/or providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; research or consulting services featuring software under a software as a Service (SaaS) model for enabling the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research and/or health and/or medical information, records or data for medical, diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; provision of mobile applications for mobile devices, such as eg smart phones and tablets, and web applications accessible through the Internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing information in the fields of life sciences, biotechnology, bioinformatics.
Class 44 — Medical & Beauty Services
Consulting services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes; consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical information, including information about drug safety and/or drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols.
Timeline
- Filed: 2015-11-09
- Registered: 2016-05-30
- Renewal due: 2025-11-09
About This Trademark
'HEALTHCARE DECISION ENGINE' is a expired trademark on the UK IPO register, owned by Molecular Health GmbH. The application (UK00914779474) was filed on 9 November 2015 and registered on 30 May 2016. The registration is set to expire on 9 November 2025.
This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 35 (advertising, business management & retail services); Class 36 (insurance & financial services); Class 38 (telecommunications services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Potter Clarkson LLP.
Frequently Asked Questions
Who owns UK trademark UK00914779474 ('HEALTHCARE DECISION ENGINE')?
UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' in Class 9, 35, 36, 38, 42, 44 is recorded on the UK IPO register as owned by Molecular Health GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00914779474 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' as expired.
Which Nice classes is UK trademark UK00914779474 registered under?
UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' is recorded in Class 9 (scientific, electrical & IT apparatus); Class 35 (advertising, business management & retail services); Class 36 (insurance & financial services); Class 38 (telecommunications services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 9: Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology; downloadable computer databases containing medical and/or health information or records about or relating to humans; downloadable comp…
When was UK trademark UK00914779474 filed?
UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' was filed at the UK IPO on 9 November 2015 and registered on 30 May 2016.
When does UK trademark UK00914779474 need to be renewed?
UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' is currently recorded as valid until 9 November 2025, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00914779474?
Potter Clarkson LLP is listed as the attorney / representative of record for UK trademark UK00914779474 for the mark 'HEALTHCARE DECISION ENGINE' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.